The use of phage display for the development of tumour targeting agents. | Adv Drug Deliv Rev;43(2-3): 165-96, 2000 Sep 30. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

The use of phage display for the development of tumour targeting agents.

Nilsson, F; Tarli, L; Viti, F; Neri, D.

Affiliation

Nilsson F; Institut für Pharmazeutische Wissenschaften, Eidgenössische Technische Hochschule, CH-8057, Zürich, Switzerland.

Adv Drug Deliv Rev ; 43(2-3): 165-96, 2000 Sep 30.

Article in En | MEDLINE | ID: mdl-10967225

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Peptide Library / Antibodies, Neoplasm / Neovascularization, Pathologic / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2000 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Peptide Library / Antibodies, Neoplasm / Neovascularization, Pathologic / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2000 Document type: Article Affiliation country: